UTILITY OF ASSESSMENT SERUM LEVELS OF VEGF, bFGF AND PDGF-BB AS SUGGESTED ANGIOGENESIS BIOMARKERS PANEL TOOL IN PATIENTS WITH BREAST CANCER
Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2016, Vol 5, Issue 1
Abstract
Introduction: Breast cancer is the commonest cause of cancer death in women worldwide. A shift in the angiogenic balance allows the up-regulation of several pro-angiogenic factors, which by ways of mutual interactions stimulate tumor angiogenesis. Angiogenic factors are produced directly by tumor through the cancer cells or indirect by inflammatory cells that infiltrate tumor. Tumoural angiogenesis is essential for the growth and metastases of breast cancer cells. Aim: The aim of the present study was to asses vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF-BB) serum levels in breast cancer patients as promising suggested panel of tool of some angiogenesis markers assisted by Bio- Plex Pro assays for diagnosis and prognosis performance in breast cancer, also as predictors to identify subgroups of patients fitting into different treatment to improve clinical outcome Method: Serum samples were collected from 68 breast cancer female patients; 32 pre-treatment and 36 under conventional chemo-radiotherapy and 10 healthy female donors as controls. Under treatment patients classified according to therapy related number of cycles regimen received to 1-4 (n=10), 5-8 (n=18), and > 8 cycles (n=8). The levels of the angiogenic markers, VEGF, bFGF and PDGF-BB, were assessed by Bio-Plex Pro assays that quantify multiple protein biomarkers. Results: There was a significant increase in VEGF and PDGF-BB (P1< 0.05) and non significant elevated bFGF (p1>0.05) in breast cancer pretreatment patients compared to controls. In patients under treatment there was a non significant elevated level in median values for each marker than the base line measurement (P2 > 0.05). A highly significant reduction serum levels for each of bFGF and PDGF-BB (P3< 0.001) and significant reduction (P3< 0.05) for VEGF after conventional adjuvant therapy treatment compared with pretreated patient serum levels. Those patients received 1-4 cycles regimen elevated non-significant median values (P4 > 0.05) for each of FGF and PDGF-BB, while VEGF showed significant elevated serum level (P4 < 0.05) in compare to baseline measurement. Those patients received 5-8 cycles regimen treatment identified non significant reduction (P5 > 0.05) in median values with baseline level of control subjects. Those patient received more than 8 cycle regimen reviled significant reduction for bFGF (P6 < 0.05) and significant elevated value (P6 > 0.05) for VEGF and non-significant (P6 > 0.05) reduction serum level for PDGF-BB compared with base line measuring value. Conclusions: our results confirmed that suggested panel tool of VEGF, bFGF and PDGF-BB serum levels assessed by Bio-Plex ® Pro Assays for Angiogenesis Factors Quantification is useful for the early detection of breast cancer within screening programs, suitable for prospective studies for breast cancer diagnosis and/ or recurrence of tumor, in prognosis and monitoring members of high- risk breast cancer families. Also, our suggested panel angiogenesis marker tool is useful for identifying subgroups of patients fitting into different treatment to improve clinical outcome. Key words: Breast cancer; Bioplex; VEGF; bFGF; PDGF-BB
Authors and Affiliations
Nahla Anber
Keywords
Related Articles
- EP ID EP417988
- DOI -
- Views 113
- Downloads 0
“STUDY OF DRUG UTILIZATION IN HOSPITAL PHARMACY & AT ITS INVENTORY CONTROL”
A study was conducted at Mahatma Gandhi Hospital Pharmacy Jaipur to study the inventory control of drug utilized for patient care, with a special focus on the drug expenditure. ABC,VED and ABC-VED matrix analysis techniq...
Interaction of phospholipase enzymes with autophagic processes; importance for cell signaling and therapeutics
Phospholipases are inherently involved in signalling mechanisms of various neurotransmitters and hormones. Cytosolic phospholipase (cPLA2) initiates pro-inflammatory lipid mediator pathways which play a critical role in...
SOLUBLITY ENHANCEMENT OF FLUCONAZOLE BY FORMULATION OF HYDROTROPIC SOLID DISPERSIONS
In the present research work mixed hydrotropic solubilization phenomenon is used to enhance the solubilization of poorly water soluble drugs. Bulk drug samples were identified by the observed IR spectra and the melting p...
A correlation study to establish a correlation between kinesiophobia with disability and mechanical factors in subjects with chronic non – specific low back pain
Back problem has become the most expensive musculoskeletal malady in the industrialized nation of the world. It is the common affliction whose specific cause and precise treatment are still baffling to the medical profes...
FORMULATION AND EVALUATION OF NASAL IN SITU GEL OF RIZATRIPTAN BENZOATE
In situ gel drug delivery systems are in elucidation form prior to supervision but once administered, endure gelation in situ, to form a gel. In the current revise nasal in situ gel of rizatriptan Benzoate was primed for...